This suggests that changes in NR2B synaptic location simultaneously facilitate different pathological aspects of AD, with decreases in synaptic NR2B resulting in synaptic dysfunction and increases in extrasynaptic NR2B yielding an aggregation of pathological tau. The gene discussed is GRIN2B; the disease is Alzheimer disease.